Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: Plasma versus PBMCs

AIDS Research and Human Retroviruses

Volumn 24, Issue 6, 2008, Pages 797-804

  Soto Ramirez, Luis E ^a   Rodriguez Diaz, Roberto ^a   Durán, Adriana S ^b   Losso, Marcelo H ^b   Salomón, Horacio ^c   Gómez Carrillo, Manuel ^c   Pampuro, Sandra ^c   Harris, D Robert ^d   Duarte, Geraldo ^e   De Souza, Ricardo S ^f   Read, Jennifer S ^g,h  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d WESTAT   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f University of Caxias Do sul   (Brazil)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ANTIVIRAL RESISTANCE; ARTICLE; BLOOD SAMPLING; CENTRAL AMERICA; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MUTATION; NUCLEIC ACID AMPLIFICATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; SOUTH AND CENTRAL AMERICA; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CARIBBEAN REGION; DISEASE TRANSMISSION, VERTICAL; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; LATIN AMERICA; LEUKOCYTES, MONONUCLEAR; MUTATION; PATIENT SELECTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 45749103316     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0246     Document Type: Article

References (21)

1. Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180.
2. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose NVP compared with zidovudine for prevention of mother-to-infant transmission of HIV-1 in Kampala, Uganda: HIVNET-012 randomised trial. Lancet 1999;354:795-802.
3. Lallemant M, Jourdain G, Le Coeur S, et al.: Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to child transmission of HIV-1 in Thailand. N Engl J Med 2004;351:217-228.
4. Centers for Disease Control and Prevention: U.S. Public Health Service Task Force Recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Week Rep 2005;47:1-30. (Most recent revision of the guidelines available at www.aidsinfo.nih.gov.)
5. European Collaborative Study: Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:458-465.
6. Giaquinto C, Rampon O, and De Rossi A: Antiretroviral therapy for prevention of mother-to-child HIV transmission. Clin Drug Invest 2006;26:611-627.
7. Bi X, Gatanaga H, Ida S, et al.: Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year. J Acquir Immune Defic Syndr 2003;34(1):1-6.
8. Duran AS, Losso MH, Salomon H, et al.: Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. AIDS 2007;21(2):199-205.
9. Read JS, Cahn P, Losso M, et al.: Management of human immunodeficiency virus-infected pregnant women at Latin America and Caribbean sites. Obstet Gynecol 2007;109:1358-1367.
10. Johnson VA, Brun-Vézinet F, Clotet B, et al.: Update of the drug resistance mutation in HIV-1: Fall 2006. Top HIV Med 2006;14:125-130.
11. Freeman GH and Halton JH: Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951;38:141-149.
12. Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
13. Palmer S, Kearney M, Maldarelli F, et al.: Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol 2005;43:406-413.
14. Chokephaibulkit K, Chaisilwattana P, Vanprapar N, Phongsamarta W, and Sutthentc R: Lack of resistant mutation development after receiving short-course zidovidine plus lamivudine to prevent mother to child HIV transmission. AIDS 2005;19:1231-1232.
15. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al.: Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001;285:2083-2093.
16. Giuliano M, Palmisano L, Galluzza C, et al.: Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission. AIDS 2003;17:1570-1573.
17. Lyons FE, Coughlan S, Byrne CM, Hopkins SM, Hall WW, and Mulcahy FM: Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy. AIDS 2005;19:63-67.
18. Paolucci S, Baldanti F, Campanini G, et al.: Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naïve and HAART patients. J Med Virol 2001;65:207-217.
19. Devereux HL, Loveday C, Youle M, et al.: Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients. AIDS Res Hum Retroviruses 2000;16:1025-1030.
20. Bon I, Gibellini D, Borderi M, et al.: Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naïve HIV-1 patients. J Clin Virol 2007;38:313-320.
21. Watts DH, Lambert J, Stiehm ER, et al., for the PACTG 185 Study Team: Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 2003;33: 585-593.